Breast Density Notifications May Increase Anxiety and Confusion, Study Finds
Table of Contents
New research indicates that informing women about breast density, intended to empower them regarding cancer risk, may inadvertently lead to increased anxiety and confusion.
Breast density notifications are becoming increasingly common in breast cancer screening programs. Designed to inform women that dense breast tissue can both elevate cancer risk and potentially obscure detection on mammograms, these notifications are currently mandated in the United States and are being rolled out across Australia. Though, a recent study published in the British Medical Journal challenges the assumed benefits of this practice, revealing that it may not be achieving its intended goal of informed decision-making.
Understanding Breast Density and Cancer Risk
Breast density refers to the proportion of fibrous and glandular tissue compared to fatty tissue in the breasts. Approximately 25 to 40 percent of women have dense breast tissue. This density can increase a woman’s risk of developing breast cancer and can make it more difficult for radiologists to identify tumors on mammograms.
While supplemental screening options like ultrasound, MRI, and contrast-enhanced mammography can improve cancer detection in women with dense breasts, these methods frequently enough come with significant out-of-pocket costs. Moreover, the long-term impact of these additional screenings on mortality rates and potential unintended consequences, such as exacerbating health inequalities, remain largely unproven.
The Study: A Randomized Controlled Trial
Researchers at the University of Sydney conducted a rigorous randomized controlled trial to assess the real-world impact of breast density notifications. The study, involving 2401 women undergoing screening at 13 breastscreen sites in Queensland between September 2023 and July 2024, divided participants into three groups:
* Group 1: Received a notification about breast density in their mammogram results letter, accompanied by a leaflet providing additional information.
* Group 2: Received a notification about breast density in their results letter, along with a link to online video-based health literacy resources.
* Group 3 (Control Group): Received standard mammogram results without any breast density notification.
Key Findings: Increased Confusion and Anxiety
The study revealed a concerning trend: women who received breast density notifications reported significantly higher levels of confusion and anxiety compared to those in the control group.
* Confusion: 11.5 percent and 9 percent of women in the two notification groups reported feeling confused after receiving a normal mammogram result alongside a breast density notification, compared to only 2.7 percent in the control group.
* Anxiety: Levels of anxiety regarding next steps for breast health were also elevated in the notification groups, reaching 20.8 percent and 20.5 percent respectively, versus 18 percent in the control group.
* Increased GP Consultations: While seemingly positive,the study also found that women who received notifications were more likely to seek further advice from their general practitioner (GP) – 22.8 percent and 19.4 percent respectively – compared to 12.9 percent in the control group. Though, researchers note that evidence-based clinical pathways for GPs to address these concerns are currently limited.
Implications for Breast Cancer Screening Programs
Lead author Dr. Brooke Nickel, from the School of Public Health at the University of sydney, emphasizes that “Creating confusion and worry for women about their breast health is not a good outcome.” The findings suggest that simply providing information about breast density may not empower women to make informed decisions, and could instead lead to unneeded anxiety and potentially strain healthcare resources.
“While it might seem positive that notified women want to seek further advice from their GP, there is currently limited evidence-based clinical pathways that GPs can offer,” Dr. Nickel explains. “Most of the suggested recommendations leave women facing out-of-pocket costs for further screening with uncertain
Worth a look